A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma

Abstract Background Although non-invasive radiological techniques are widely applied in kidney renal clear cell carcinoma (KIRC) diagnosis, more than 50% of KIRCs are detected incidentally during the diagnostic procedures to identify renal cell carcinoma (RCC). Thus, sensitive and accurate KIRC diag...

Full description

Bibliographic Details
Main Authors: Zhenyu Wen, Yingqi Li, Zhengping Zhao, Rongkang Li, Xinji Li, Chong Lu, Chen Sun, Wenkang Chen, Zhenjian Ge, Liangchao Ni, Yongqing Lai
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-023-03187-z
_version_ 1797355496234024960
author Zhenyu Wen
Yingqi Li
Zhengping Zhao
Rongkang Li
Xinji Li
Chong Lu
Chen Sun
Wenkang Chen
Zhenjian Ge
Liangchao Ni
Yongqing Lai
author_facet Zhenyu Wen
Yingqi Li
Zhengping Zhao
Rongkang Li
Xinji Li
Chong Lu
Chen Sun
Wenkang Chen
Zhenjian Ge
Liangchao Ni
Yongqing Lai
author_sort Zhenyu Wen
collection DOAJ
description Abstract Background Although non-invasive radiological techniques are widely applied in kidney renal clear cell carcinoma (KIRC) diagnosis, more than 50% of KIRCs are detected incidentally during the diagnostic procedures to identify renal cell carcinoma (RCC). Thus, sensitive and accurate KIRC diagnostic methods are required. Therefore, in this study, we aimed to identify KIRC-associated microRNAs (miRNAs). Methods This three-phase study included 224 participants (112 each of patients with KIRC and healthy controls (NCs)). RT-qPCR was used to evaluate miRNA expression in KIRC and NC samples. Receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were used to predict the usefulness of serum miRNAs in KIRC diagnosis. In addition, we performed survival and bioinformatics analyses. Results We found that miR-1-3p, miR-129-5p, miR-146b-5p, miR-187-3p, and miR-200a-3p were significantly differentially expressed in patients with KIRC. A panel consisting of three miRNAs (miR-1-3p, miR-129-5p, and miR-146b-5p) had an AUC of 0.895, ranging from 0.848 to 0.942. In addition, using the GEPIA database, we found that the miRNAs were associated with CREB5. According to the survival analysis, miR-146b-5p overexpression was indicative of a poorer prognosis in patients with KIRC. Conclusions The identified three-miRNA panel could serve as a non-invasive indicator for KIRC and CREB5 as a potential target gene for KIRC treatment.
first_indexed 2024-03-08T14:11:59Z
format Article
id doaj.art-4133e122a20b463cb2279d64da0a3bb4
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-03-08T14:11:59Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-4133e122a20b463cb2279d64da0a3bb42024-01-14T12:37:16ZengBMCCancer Cell International1475-28672024-01-0124111010.1186/s12935-023-03187-zA serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinomaZhenyu Wen0Yingqi Li1Zhengping Zhao2Rongkang Li3Xinji Li4Chong Lu5Chen Sun6Wenkang Chen7Zhenjian Ge8Liangchao Ni9Yongqing Lai10Guangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalGuangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, Department of Urology, Peking University Shenzhen HospitalAbstract Background Although non-invasive radiological techniques are widely applied in kidney renal clear cell carcinoma (KIRC) diagnosis, more than 50% of KIRCs are detected incidentally during the diagnostic procedures to identify renal cell carcinoma (RCC). Thus, sensitive and accurate KIRC diagnostic methods are required. Therefore, in this study, we aimed to identify KIRC-associated microRNAs (miRNAs). Methods This three-phase study included 224 participants (112 each of patients with KIRC and healthy controls (NCs)). RT-qPCR was used to evaluate miRNA expression in KIRC and NC samples. Receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were used to predict the usefulness of serum miRNAs in KIRC diagnosis. In addition, we performed survival and bioinformatics analyses. Results We found that miR-1-3p, miR-129-5p, miR-146b-5p, miR-187-3p, and miR-200a-3p were significantly differentially expressed in patients with KIRC. A panel consisting of three miRNAs (miR-1-3p, miR-129-5p, and miR-146b-5p) had an AUC of 0.895, ranging from 0.848 to 0.942. In addition, using the GEPIA database, we found that the miRNAs were associated with CREB5. According to the survival analysis, miR-146b-5p overexpression was indicative of a poorer prognosis in patients with KIRC. Conclusions The identified three-miRNA panel could serve as a non-invasive indicator for KIRC and CREB5 as a potential target gene for KIRC treatment.https://doi.org/10.1186/s12935-023-03187-zMicroRNAKidney renal clear cell carcinomaDiagnosisBiomarkerBioinformatics
spellingShingle Zhenyu Wen
Yingqi Li
Zhengping Zhao
Rongkang Li
Xinji Li
Chong Lu
Chen Sun
Wenkang Chen
Zhenjian Ge
Liangchao Ni
Yongqing Lai
A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma
Cancer Cell International
MicroRNA
Kidney renal clear cell carcinoma
Diagnosis
Biomarker
Bioinformatics
title A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma
title_full A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma
title_fullStr A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma
title_full_unstemmed A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma
title_short A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma
title_sort serum panel of three micrornas may serve as possible biomarkers for kidney renal clear cell carcinoma
topic MicroRNA
Kidney renal clear cell carcinoma
Diagnosis
Biomarker
Bioinformatics
url https://doi.org/10.1186/s12935-023-03187-z
work_keys_str_mv AT zhenyuwen aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT yingqili aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT zhengpingzhao aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT rongkangli aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT xinjili aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT chonglu aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT chensun aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT wenkangchen aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT zhenjiange aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT liangchaoni aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT yongqinglai aserumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT zhenyuwen serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT yingqili serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT zhengpingzhao serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT rongkangli serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT xinjili serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT chonglu serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT chensun serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT wenkangchen serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT zhenjiange serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT liangchaoni serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma
AT yongqinglai serumpanelofthreemicrornasmayserveaspossiblebiomarkersforkidneyrenalclearcellcarcinoma